Pharmafile Logo

COUCH Medcomms

- PMLiVE

Editas Medicine names James Mullen as chairman

He has previously served as CEO of Patheon

- PMLiVE

Novo Nordisk appoints new general manager

Pinder Sahota also becomes the corporate vice president, UK

- PMLiVE

Accelerating diagnosis in rare disease

Biopharmaceutical companies can drive effective partnerships and improve outcomes for all stakeholders and patients in the area of rare disease.

- PMLiVE

Is agile working benefiting the employee or the organisation?

The late Stephen Hawking’s quote, “Intelligence is the ability to adapt to change” really resonates with me when thinking about agile working.We are undoubtedly living through a fundamental transformation in...

No incentive for a cure

The paradox of ‘cost-effective but unaffordable’ life-saving medicines

- PMLiVE

Pfizer’s plans for Inlyta go awry with failed adjuvant trial

Interim data suggested there was no improvement on disease-free survival compared to placebo

- PMLiVE

Parexel launches medical writing solutions business

Will develop a variety of communication services

- PMLiVE

No one is listening to you!

We know it is harsh but you know how frustrating it is. You want them to embrace change but they’ve got cloth ears. That’s why we have produced a guide,...

Page & Page Health

How can pharma engage with key decision-makers in new, collaborative NHS care models?

Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach

Wilmington Healthcare

- PMLiVE

Merck’s Keytruda scores in frontline lung cancer yet again

Drug improved overall survival as a monotherapy, which rival BMS’ Opdivo was unable to show

- PMLiVE

AbbVie’s upadacitinib aces phase III trial

Arthritis drug outperformed both placebo and Humira in the study

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links